Generic Name and Formulations:
Ketoconazole 2%; foam; contains alcohol.
Indications for EXTINA:
Topical treatment of seborrheic dermatitis in immunocompetent patients.
Apply twice daily for 4 weeks. Dispense an amount that will cover the affected area(s) into cap or other cool surface. Pick up a small amount of foam with fingertips and massage into affected area(s) until foam disappears.
<12yrs: not established.
Not for fungal infections. Avoid contact with eyes, mucous membranes. Product is flammable. Pregnancy. Nursing mothers.
Application site reactions (eg, burning), contact sensitization (eg, photoallergenicity).
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Age of Onset of Bipolar Disorder Linked With Substance Use Disorders
- Mind-Body Therapy and Psychiatry: Ancient Tools for Modern Practice
- Marijuana Use Associated With Poorer Depression Outcomes, Increased Suicidal Ideation
- Short Forms of Parent General Behavior Inventory Reliable at Identifying Youth Mood Symptoms
- Low Testosterone Linked With Social Anxiety in Boys With Klinefelter Syndrome
- The Psychology of Hoarding Disorder: Approaches for Treatment
- Smartphone Applications for Depression and Anxiety: Are They Ready for Widespread Use?
- The Many Misconceptions of Catatonia: Treatment Is Often Successful With the Right Knowledge
- Digital Media Engagement Associated With ADHD Symptoms in Adolescents
- Strong Social Networks May Mitigate the Effects of Childhood Adversity
- Unexpected Effect of Substance Use Disorders on Recovery From Bipolar Depression
- Republican Opposition to Obamacare: What's Done, What's to Come
- Early Childhood Out-of-Home Placement Associated With Adverse Outcomes in Adulthood
- Opioid Use Disorder Prevalence at Delivery on the Rise in the US, According to CDC
- Integrating Treatments for Opioid Use Disorder and Infectious Diseases